ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes

from Applied Clinical Trials · host Applied Clinical Trials

In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss evolving sponsor oversight in site selection and protocol design, and review the FDA’s decision to update menopausal hormone therapy labels for clarity and safety.

Episode metadata supplied by the publisher feed · Published Nov 12, 2025

Embed this episode

Attribution link and audio player

Ready to play

ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes

0:00 1:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Applied Clinical Trials?

This episode is 1 minute long.

When was this Applied Clinical Trials episode published?

This episode was published on November 12, 2025.

Can I download this Applied Clinical Trials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!